Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Julija Simiene"'
Autor:
Nadežda Lachej, Violeta Jonušienė, Augustina Mažeikė, Aušra Sasnauskienė, Daiva Dabkevičienė, Julija Šimienė, Kęstutis Sužiedėlis, Janina Didžiapetrienė
Publikováno v:
Acta Medica Lituanica, Vol 26, Iss 3 (2020)
Background. Endometrial cancer is the sixth most frequent type of cancer among women worldwide. Type I adenocarcinomas account for 80–85% of endometrial cancer cases and sometimes require more aggressive treatment than the remaining part of this gr
Externí odkaz:
https://doaj.org/article/817c4c45d0574deb8c5e067d931eeb78
Autor:
Julija Simiene, Daiva Dabkeviciene, Diana Stanciute, Rimvile Prokarenkaite, Valerija Jablonskiene, Renatas Askinis, Kamile Normantaite, Saulius Cicenas, Kestutis Suziedelis
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background The development of drug resistance and high mortality rates are the major problems observed in non-small cell lung cancer (NSCLC). Biomarkers indicating and predicting disease development towards these unfavorable directions are t
Externí odkaz:
https://doaj.org/article/2a7e9f3527304019a3e5683e37dda52d
Autor:
Nadezda Lachej, Daiva Dabkeviciene, Julija Simiene, Rasa Sabaliauskaite, Violeta Jonusiene, Vytautas Brasiunas, Ausra Sasnauskiene, Ieva Vaicekauskaite, Birute Brasiuniene, Daiva Kanopiene, Kestutis Suziedelis, Janina Didziapetriene
Publikováno v:
Journal of Oncology, Vol 2022 (2022)
Journal of Oncology
Journal of Oncology
New molecular biomarkers that could have an independent prognostic value in endometrial cancer are currently under investigation. Recently, it was suggested that genetic changes in the Notch signaling pathway could be associated with the development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97fa3a2bf197b1b4a5f55b5d0ff8f232
Autor:
Kestutis Suziedelis, Feliksas Jankevičius, Marius Kincius, Albertas Ulys, Julija Simiene, Alvydas Vezelis, Daiva Dabkeviciene, Sonata Jarmalaite
Publikováno v:
Journal of Oncology, Vol 2021 (2021)
Journal of Oncology
Journal of oncology, London : Hindawi, 2021, vol. 2021, art. no. 8820366, p. 1-6
Journal of Oncology
Journal of oncology, London : Hindawi, 2021, vol. 2021, art. no. 8820366, p. 1-6
A set of prostate tumors tend to grow slowly and do not require active treatment. Therefore, stratification between patients with clinically significant and clinically insignificant prostate cancer (PC) remains a vital issue to avoid overtreatment. F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95c730670a4805d9c231c8fa81524594
https://doaj.org/article/bb4f2f66cd9e4bb39eb8fe6d31d945b4
https://doaj.org/article/bb4f2f66cd9e4bb39eb8fe6d31d945b4
Autor:
Ingrida Meskinyte, Ryte Rynkeviciene, Julija Simiene, Edita Miseikyte Kaubriene, Egle Strainiene, Jonas Cicenas, Vaidotas Stankevicius, Jurgita Usinskiene, Kestutis Suziedelis
Publikováno v:
Cancers, Vol 11, Iss 1, p 17 (2018)
Cancers
Cancers
Glioma is the most aggressive brain tumor of the central nervous system. The ability of glioma cells to migrate, rapidly diffuse and invade normal adjacent tissue, their sustained proliferation, and heterogeneity contribute to an overall survival of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b38fcfe1cf2b2a84db431ae15b9da7a
http://dspace.vgtu.lt/handle/1/3943
http://dspace.vgtu.lt/handle/1/3943
